Skip to main content
Erschienen in: Current Cardiology Reports 11/2013

01.11.2013 | Hypertension (M Sorrentino, Section Editor)

Home Blood Pressure Monitoring Is Better Predictor of Cardiovascular Disease and Target Organ Damage than Office Blood Pressure: A Systematic Review and Meta-Analysis

verfasst von: Sandra C. Fuchs, Renato G. B. de Mello, Felipe C. Fuchs

Erschienen in: Current Cardiology Reports | Ausgabe 11/2013

Einloggen, um Zugang zu erhalten

Abstract

The available, albeit rare, evidence indicates the superiority of home- over office blood pressure monitoring (HBPM vs OBP) to predict cardiovascular (CV) outcomes. We performed a systematic review to update the efficacy of HBPM vs OBP as predictors of all-cause mortality, CV death, and target organ damage. Two reviewers independently performed the literature search in various databases. A meta-analysis with a fixed-effect model was conducted, and the heterogeneity and inconsistency indices were assessed. The search identified 291 articles, of which 10 were eligible for inclusion in the study, and five articles published in 2012 were included in the meta-analysis. A previous meta-analysis showed the superiority of HBPM over OBP to predict all-cause mortality, CV mortality, and CV events. The meta-analysis of articles published in 2012 identified that HBPM was also a better predictor of proteinuria than OBP. In conclusion, the results of our systematic review and meta-analysis confirm that HBPM is a better predictor of CV outcomes and target organ damage than OBP.
Literatur
1.
Zurück zum Zitat Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13.PubMedCrossRef Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13.PubMedCrossRef
2.
Zurück zum Zitat Shimbo D, Pickering TG, Spruill TM, Abraham D, Schwartz JE, Gerin W. Relative utility of home, ambulatory, and office blood pressures in the prediction of end-organ damage. Am J Hypertens. 2007;20:476–82.PubMedCrossRef Shimbo D, Pickering TG, Spruill TM, Abraham D, Schwartz JE, Gerin W. Relative utility of home, ambulatory, and office blood pressures in the prediction of end-organ damage. Am J Hypertens. 2007;20:476–82.PubMedCrossRef
3.
Zurück zum Zitat Stergiou GS, Argyraki KK, Moyssakis I, Mastorantonakis SE, Achimastos AD, Karamanos VG, et al. Home blood pressure is as reliable as ambulatory blood pressure in predicting target-organ damage in hypertension. Am J Hypertens. 2007;20:616–21.PubMedCrossRef Stergiou GS, Argyraki KK, Moyssakis I, Mastorantonakis SE, Achimastos AD, Karamanos VG, et al. Home blood pressure is as reliable as ambulatory blood pressure in predicting target-organ damage in hypertension. Am J Hypertens. 2007;20:616–21.PubMedCrossRef
4.
Zurück zum Zitat • Bliziotis IA, Destounis A, Stergiou GS. Home vs ambulatory and office blood pressure in predicting target organ damage in hypertension: a systematic review and meta-analysis. J Hypertens. 2012;30:1289–99. This systematic review addressed HBPM vs OBP as predictors of LVMI and several parameters of target organ damage. PubMedCrossRef • Bliziotis IA, Destounis A, Stergiou GS. Home vs ambulatory and office blood pressure in predicting target organ damage in hypertension: a systematic review and meta-analysis. J Hypertens. 2012;30:1289–99. This systematic review addressed HBPM vs OBP as predictors of LVMI and several parameters of target organ damage. PubMedCrossRef
5.
Zurück zum Zitat Sheikh S, Sinha AD, Agarwal R. Home blood pressure monitoring: how good a predictor of long-term risk? Curr Hypertens Rep. 2011;13:192–9.PubMedCrossRef Sheikh S, Sinha AD, Agarwal R. Home blood pressure monitoring: how good a predictor of long-term risk? Curr Hypertens Rep. 2011;13:192–9.PubMedCrossRef
6.
Zurück zum Zitat Ward AM, Takahashi Pickering TG, Miller NH, Ogedegbe G, et al. Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension. 2008;52:10–29.CrossRef Ward AM, Takahashi Pickering TG, Miller NH, Ogedegbe G, et al. Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension. 2008;52:10–29.CrossRef
7.
Zurück zum Zitat Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560–72.PubMedCrossRef Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560–72.PubMedCrossRef
8.
Zurück zum Zitat •• Ward AM, Takahashi O, Stevens R, Heneghan C. Home measurement of blood pressure and cardiovascular disease: systematic review and meta-analysis of prospective studies. J Hypertens. 2012;30:449–56. This systematic review verified HBPM and OBP as predictors of all-cause and cardiovascular mortality, using an appropriate methodology. PubMedCrossRef •• Ward AM, Takahashi O, Stevens R, Heneghan C. Home measurement of blood pressure and cardiovascular disease: systematic review and meta-analysis of prospective studies. J Hypertens. 2012;30:449–56. This systematic review verified HBPM and OBP as predictors of all-cause and cardiovascular mortality, using an appropriate methodology. PubMedCrossRef
9.
Zurück zum Zitat Fuchs SC, Ferreira-da-Silva AL, Moreira LB, Neyeloff JL, Fuchs FC, Gus M, et al. Efficacy of isolated home blood pressure monitoring for blood pressure control: randomized controlled trial with ambulatory blood pressure monitoring – MONITOR study. J Hypertens. 2012;30:75–80.PubMedCrossRef Fuchs SC, Ferreira-da-Silva AL, Moreira LB, Neyeloff JL, Fuchs FC, Gus M, et al. Efficacy of isolated home blood pressure monitoring for blood pressure control: randomized controlled trial with ambulatory blood pressure monitoring – MONITOR study. J Hypertens. 2012;30:75–80.PubMedCrossRef
10.
Zurück zum Zitat Picon RV, Fuchs FD, Moreira LB, Fuchs SC. Prevalence of hypertension among elderly persons in urban Brazil: a systematic review with meta-analysis. Am J Hypertens. 2013;26:541–8.PubMedCrossRef Picon RV, Fuchs FD, Moreira LB, Fuchs SC. Prevalence of hypertension among elderly persons in urban Brazil: a systematic review with meta-analysis. Am J Hypertens. 2013;26:541–8.PubMedCrossRef
11.
Zurück zum Zitat Picon RV, Fuchs FD, Moreira LB, Riegel G, Fuchs SC. Trends in prevalence of hypertension in Brazil: a systematic review with meta-analysis. PLoS One. 2012;7:e48255.PubMedCrossRef Picon RV, Fuchs FD, Moreira LB, Riegel G, Fuchs SC. Trends in prevalence of hypertension in Brazil: a systematic review with meta-analysis. PLoS One. 2012;7:e48255.PubMedCrossRef
12.
Zurück zum Zitat Von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147:573–7.CrossRef Von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147:573–7.CrossRef
13.
Zurück zum Zitat Freemantle N, Mason JM, Haines A, Eccles MP. CONSORT: an important step toward evidence-based health care. Consolidated Standards of Reporting Trials. Ann Intern Med. 1997;126:81–3.PubMedCrossRef Freemantle N, Mason JM, Haines A, Eccles MP. CONSORT: an important step toward evidence-based health care. Consolidated Standards of Reporting Trials. Ann Intern Med. 1997;126:81–3.PubMedCrossRef
14.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med. 2009;3:e123–30.PubMed Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med. 2009;3:e123–30.PubMed
15.
Zurück zum Zitat Neyeloff JL, Fuchs SC, Moreira LB. Meta-analyses and Forest plots using a Microsoft excel spreadsheet: step-by-step guide focusing on descriptive data analysis. BMC Res Notes. 2012;5:52.PubMedCrossRef Neyeloff JL, Fuchs SC, Moreira LB. Meta-analyses and Forest plots using a Microsoft excel spreadsheet: step-by-step guide focusing on descriptive data analysis. BMC Res Notes. 2012;5:52.PubMedCrossRef
16.
Zurück zum Zitat Yano Y, Hoshide S, Shimizu M, Eguchi K, Ishikawa J, et al. Association of home and ambulatory blood pressure changes with changes in cardiovascular biomarkers during antihypertensive treatment. Am J Hypertens. 2012;25:306–12.PubMedCrossRef Yano Y, Hoshide S, Shimizu M, Eguchi K, Ishikawa J, et al. Association of home and ambulatory blood pressure changes with changes in cardiovascular biomarkers during antihypertensive treatment. Am J Hypertens. 2012;25:306–12.PubMedCrossRef
17.
Zurück zum Zitat Ishikawa J, Hoshide S, Eguchi K, Ishikawa S, Shimada K. Nighttime home blood pressure and the risk of hypertensive target organ damage. Hypertension. 2012;60:921–8.PubMedCrossRef Ishikawa J, Hoshide S, Eguchi K, Ishikawa S, Shimada K. Nighttime home blood pressure and the risk of hypertensive target organ damage. Hypertension. 2012;60:921–8.PubMedCrossRef
18.
Zurück zum Zitat •• Hara A, Tanaka K, Ohkubo T, Kondo T, Kikuya M, et al. Ambulatory versus home versus clinic blood pressure and the association with subclinical cerebrovascular diseases: The Ohasama Study. Hypertension. 2012;59:22–8. This article provided evidence of the independent prognostic value of HBPM vs OBP in assessing cerebrovascular disease, among 1007 subjects of the general population of Ohasama, Japan. PubMedCrossRef •• Hara A, Tanaka K, Ohkubo T, Kondo T, Kikuya M, et al. Ambulatory versus home versus clinic blood pressure and the association with subclinical cerebrovascular diseases: The Ohasama Study. Hypertension. 2012;59:22–8. This article provided evidence of the independent prognostic value of HBPM vs OBP in assessing cerebrovascular disease, among 1007 subjects of the general population of Ohasama, Japan. PubMedCrossRef
19.
Zurück zum Zitat Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.PubMedCrossRef Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.PubMedCrossRef
Metadaten
Titel
Home Blood Pressure Monitoring Is Better Predictor of Cardiovascular Disease and Target Organ Damage than Office Blood Pressure: A Systematic Review and Meta-Analysis
verfasst von
Sandra C. Fuchs
Renato G. B. de Mello
Felipe C. Fuchs
Publikationsdatum
01.11.2013
Verlag
Springer US
Erschienen in
Current Cardiology Reports / Ausgabe 11/2013
Print ISSN: 1523-3782
Elektronische ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-013-0413-z

Weitere Artikel der Ausgabe 11/2013

Current Cardiology Reports 11/2013 Zur Ausgabe

Ischemic Heart Disease (D Mukherjee, Section Editor)

The Evolving Role of Cardiac Troponin in the Evaluation of Cardiac Disorders

Hypertension (M Sorrentino, Section Editor)

Obstructive Sleep Apnea: Incidence and Impact on Hypertension?

Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)

Screening for and Management of Elevated Lp(a)

Congenital Heart Disease (J Deanfield, Section Editor)

Exercise: Friend or Foe in Adult Congenital Heart Disease?

Ist Fasten vor Koronarinterventionen wirklich nötig?

Wenn Eingriffe wie eine Koronarangiografie oder eine Koronarangioplastie anstehen, wird häufig empfohlen, in den Stunden zuvor nüchtern zu bleiben. Ein französisches Forscherteam hat diese Maßnahme hinterfragt.

PET kann infarktgefährdete Koronararterien entdecken

04.06.2024 Koronare Herzerkrankung Nachrichten

Der Nachweis aktiver Plaques mittels 18F-Natriumfluorid-PET hilft nicht nur, infarktgefährdete Patienten, sondern auch infarktgefährdete Koronararterien zu erkennen. Von einer gezielten Behandlung vulnerabler Plaques ist man trotzdem weit entfernt.

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

03.06.2024 Semaglutid Nachrichten

Der GLP-1-Agonist Semaglutid hat in der FLOW-Studie bewiesen, dass sich damit die Progression chronischer Nierenerkrankungen bei Patienten mit Typ-2-Diabetes bremsen lässt. Auch in kardiovaskulärer Hinsicht war die Therapie erfolgreich.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.